Cargando…

Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways

Alteration in gut microbiota has been associated with COVID-19. However, the underlying mechanisms remain poorly understood. Here, we outlined three potential interconnected mechanistic pathways leading to gut dysbiosis as an adverse outcome following SARS-CoV-2 presence in the gastrointestinal trac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clerbaux, Laure-Alix, Fillipovska, Julija, Muñoz, Amalia, Petrillo, Mauro, Coecke, Sandra, Amorim, Maria-Joao, Grenga, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505288/ https://www.ncbi.nlm.nih.gov/pubmed/36143044 http://dx.doi.org/10.3390/jcm11185400

Ejemplares similares

Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19
por: Clerbaux, Laure-Alix, et al.
Publicado: (2022)

Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework
por: Shahbaz, Muhammad Ali, et al.
Publicado: (2022)

Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
por: Clerbaux, Laure-Alix, et al.
Publicado: (2022)

CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework
por: Carusi, Annamaria, et al.
Publicado: (2023)

Capturing the applicability of in vitro-in silico membrane transporter data in chemical risk assessment and biomedical research
por: Clerbaux, Laure-Alix, et al.
Publicado: (2018)

The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
por: Hogberg, Helena T., et al.
Publicado: (2022)

Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease
por: Jo, Sungyang, et al.
Publicado: (2022)

Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 −/− mouse model
por: Behary, J., et al.
Publicado: (2021)

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
por: Pierantonelli, Irene, et al.
Publicado: (2017)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Gut Dysbiosis and Kidney Diseases
por: Cao, Chujin, et al.
Publicado: (2022)

Developmental exposure to silver nanoparticles leads to long term gut dysbiosis and neurobehavioral alterations
por: Lyu, Zhen, et al.
Publicado: (2021)

COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
por: Aldhafiri, Fahad K.
Publicado: (2022)

Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice
por: Hao, Yan, et al.
Publicado: (2022)

Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
por: Pierantonelli, Irene, et al.
Publicado: (2017)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Dysbiosis in Patients with Anorexia Nervosa
por: Morita, Chihiro, et al.
Publicado: (2015)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Hyperoxia provokes gut dysbiosis in rats
por: Xing, Zhouxiong, et al.
Publicado: (2020)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Gut dysbiosis and mortality in hemodialysis patients
por: Lin, Ting-Yun, et al.
Publicado: (2021)

Epigenetic Regulation of Gut Microbial Dysbiosis
por: Srivastava, Shivani, et al.
Publicado: (2021)

Gut dysbiosis and body composition in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?
por: Dicks, Leon M. T., et al.
Publicado: (2022)

Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner
por: Carrillo-Salinas, Francisco J, et al.
Publicado: (2020)

Retraction: Human gut microbiota: dysbiosis and manipulation
Publicado: (2013)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

Gut-lung axis and dysbiosis in COVID-19
por: AKTAS, Busra, et al.
Publicado: (2020)

Current Perspectives on Gut Microbiome Dysbiosis and Depression
por: Capuco, Alexander, et al.
Publicado: (2020)

Gut microbial dysbiosis in individuals with Sjögren’s syndrome
por: Mendez, Roberto, et al.
Publicado: (2020)

Gut Bacterial Dysbiosis in Children with Intractable Epilepsy
por: Lee, Kihyun, et al.
Publicado: (2020)

Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
por: Huang, Yinhua, et al.
Publicado: (2021)

Risk Factors for Gut Dysbiosis in Early Life
por: Parkin, Kimberley, et al.
Publicado: (2021)

Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid
por: Low, Liying, et al.
Publicado: (2022)

Gut dysbiosis is associated with acceleration of lupus nephritis
por: Valiente, Giancarlo R., et al.
Publicado: (2022)

Gut microbiota and immunity relevance in eubiosis and dysbiosis
por: Al-Rashidi, Hanan E.
Publicado: (2022)

Pain and Opioid-Induced Gut Microbial Dysbiosis
por: Thomas, Karen R., et al.
Publicado: (2022)

The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders
por: Anand, Nikhilesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ng96ej19r4oiqmoboclbggke9d